Fortress Biotech Statistics
Total Valuation
FBIO has a market cap or net worth of $62.70 million. The enterprise value is -$50.54 million.
| Market Cap | 62.70M |
| Enterprise Value | -50.54M |
Important Dates
The last earnings date was Friday, November 13, 2026, before market open.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FBIO has 33.35 million shares outstanding. The number of shares has increased by 28.63% in one year.
| Current Share Class | 33.35M |
| Shares Outstanding | 33.35M |
| Shares Change (YoY) | +28.63% |
| Shares Change (QoQ) | +6.15% |
| Owned by Insiders (%) | 22.17% |
| Owned by Institutions (%) | 19.11% |
| Float | 21.06M |
Valuation Ratios
The trailing PE ratio is 0.70.
| PE Ratio | 0.70 |
| Forward PE | n/a |
| PS Ratio | 0.90 |
| Forward PS | 1.42 |
| PB Ratio | 0.39 |
| P/TBV Ratio | 0.46 |
| P/FCF Ratio | 0.50 |
| P/OCF Ratio | 0.50 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.93, with a Debt / Equity ratio of 0.22.
| Current Ratio | 2.93 |
| Quick Ratio | 2.78 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.31 |
| Interest Coverage | -3.19 |
Financial Efficiency
Return on equity (ROE) is 102.49% and return on invested capital (ROIC) is -45.58%.
| Return on Equity (ROE) | 102.49% |
| Return on Assets (ROA) | -8.11% |
| Return on Invested Capital (ROIC) | -45.58% |
| Return on Capital Employed (ROCE) | -14.37% |
| Weighted Average Cost of Capital (WACC) | 15.79% |
| Revenue Per Employee | $897,346 |
| Profits Per Employee | $1.18M |
| Employee Count | 78 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 2.42 |
Taxes
In the past 12 months, FBIO has paid $4.75 million in taxes.
| Income Tax | 4.75M |
| Effective Tax Rate | 3.69% |
Stock Price Statistics
The stock price has decreased by -28.24% in the last 52 weeks. The beta is 1.26, so FBIO's price volatility has been higher than the market average.
| Beta (5Y) | 1.26 |
| 52-Week Price Change | -28.24% |
| 50-Day Moving Average | 2.14 |
| 200-Day Moving Average | 2.71 |
| Relative Strength Index (RSI) | 42.46 |
| Average Volume (20 Days) | 211,292 |
Short Selling Information
The latest short interest is 4.61 million, so 13.83% of the outstanding shares have been sold short.
| Short Interest | 4.61M |
| Short Previous Month | 4.52M |
| Short % of Shares Out | 13.83% |
| Short % of Float | 21.90% |
| Short Ratio (days to cover) | 19.16 |
Income Statement
In the last 12 months, FBIO had revenue of $69.99 million and earned $91.84 million in profits. Earnings per share was $2.68.
| Revenue | 69.99M |
| Gross Profit | 46.28M |
| Operating Income | -29.96M |
| Pretax Income | 128.86M |
| Net Income | 91.84M |
| EBITDA | -25.45M |
| EBIT | -29.96M |
| Earnings Per Share (EPS) | $2.68 |
Balance Sheet
The company has $152.19 million in cash and $38.95 million in debt, with a net cash position of $113.24 million or $3.40 per share.
| Cash & Cash Equivalents | 152.19M |
| Total Debt | 38.95M |
| Net Cash | 113.24M |
| Net Cash Per Share | $3.40 |
| Equity (Book Value) | 177.02M |
| Book Value Per Share | 4.78 |
| Working Capital | 138.60M |
Cash Flow
In the last 12 months, operating cash flow was $125.83 million and capital expenditures -$86,000, giving a free cash flow of $125.75 million.
| Operating Cash Flow | 125.83M |
| Capital Expenditures | -86,000 |
| Depreciation & Amortization | 4.51M |
| Net Borrowing | 55,000 |
| Free Cash Flow | 125.75M |
| FCF Per Share | $3.77 |
Margins
Gross margin is 66.11%, with operating and profit margins of -42.80% and 143.05%.
| Gross Margin | 66.11% |
| Operating Margin | -42.80% |
| Pretax Margin | 184.11% |
| Profit Margin | 143.05% |
| EBITDA Margin | -36.36% |
| EBIT Margin | -42.80% |
| FCF Margin | 179.66% |
Dividends & Yields
FBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -28.63% |
| Shareholder Yield | -28.63% |
| Earnings Yield | 142.39% |
| FCF Yield | 200.55% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 119.26% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on October 10, 2023. It was a reverse split with a ratio of 1:15.
| Last Split Date | Oct 10, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |